For decades, synthetic biologists have been developing gene circuits that can be transferred into cells for applications such ...
MedPage Today on MSN
Endocrine Therapy Resistance in HR+/HER2- Breast Cancer: A Common Clinical Challenge
Endocrine therapy typically slows cell cycle progression by reducing cyclin D1, which partners with CDK4/6 to promote cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback